Clinical Trials Logo

Clinical Trial Summary

This is a multi-center, non-randomized post marketing surveillance registry including up to 125 patients treated with the PerX360º System™. Patients will receive a follow-up evaluation at the per physician defined time points: at discharge, an Interim 1 visit (1 month), an Interim 2 visit (3-6 months) and a Final visit (12 months). Imaging obtained at visits should be per standard of care.


Clinical Trial Description

For all patients participating in the registry, the following outcomes will be analyzed:

- Change in pain score on the Visual Analog Scale(VAS) from baseline for leg pain

- Change in pain score on the Visual Analog Scale(VAS) from baseline for back pain

- Change in Oswestry Disability Index (ODI) score from baseline

- Proportion of patients with a device related complication

- Proportion of patients with lack of revision, removal, or reoperation

- Proportion of patients with radiographic fusion ;


Study Design

Observational Model: Case-Only


Related Conditions & MeSH terms


NCT number NCT01796535
Study type Observational [Patient Registry]
Source Interventional Spine, Inc.
Contact Michelle Butler
Phone 858 220 6904
Email mbutler@i-spineinc.com
Status Recruiting
Phase N/A
Start date November 2012
Completion date June 2013

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05067127 - Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis Phase 3
Active, not recruiting NCT05809531 - An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis Phase 3
Completed NCT01343693 - MaxAn Post Market Surveillance Validation
Available NCT04729062 - C3G/Primary IC-MPGN EAP